Breathing pattern in patients with Parkinson's disease

Respiration Physiology

Volumn 118, Issue 2-3, 1999, Pages 163-172

  Vercueil, Laurent ^a   Linard, Jean Pierre ^b   Wuyam, Bernard ^b   Pollak, Pierre ^a   Benchetrit, Gila ^b  

^a INSERM   (France)

^b UNIV GRENOBLE ALPES   (France)

Author keywords

Disease, Parkinson; Mammals, humans; Pattern of breathing, Parkinson's disease; Pharmacological agents, levodopa

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; LEVODOPA;

ADULT; AGED; ARTICLE; BREATHING MUSCLE; BREATHING PATTERN; CLINICAL ARTICLE; CLINICAL TRIAL; DYSKINESIA; FEMALE; HUMAN; INTERCOSTAL MUSCLE; LUNG VENTILATION; MALE; MOTOR PERFORMANCE; MUSCLE FUNCTION; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PLETHYSMOGRAPHY; PRIORITY JOURNAL;

AGED; ANTIPARKINSON AGENTS; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; RESPIRATORY MECHANICS;

EID: 0032724582     PISSN: 00345687     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-5687(99)00075-4     Document Type: Article

References (23)

1. Basom D.A., Clement I.D., Dorrington K.L., Robbins P.A. Effects of dopamine and domperidone on ventilation during isocapnic hypoxia in humans. Respir. Physiol. 85:1991;319-328.
2. Bolme P., Fuxe K., Hökfelt T., Goldstein M. Studies on the role of dopamine in cardiovascular and respiratory control central versus peripheral mechanisms. Adv. Biochem. Psychopharmacol. 16:1977;281-290.
3. De Bruin P.F.C., De Bruin V.M.S., Lees A.J., Pride N.B. Effects of treatment on airway dynamics and respiratory muscle strength in Parkinson's disease. Am. Rev. Respir. Dis. 148:1993;1576-1580.
4. De Keyser J., Vinken W. L-dopa-induced respiratory disturbance in Parkinson's disease suppressed by tiapride. Neurology. 35:1985;235-237.
5. Duron B. Intercostal and diaphragmatic muscle. Ending and afferents. Hornbein T.F. Regulation of Breathing, Part 1. 1981;473-540 Marcel Dekker, New-York Basel.
6. Estenne M.N., Hubert M., De Troyer A. Respiratory-muscle involvment in Parkinsons's disease. New Engl. J. Med. 31:1984;1516-1517.
7. Fahn S., Elton R. Unified Parkinson's Disease Rating Scale. Fahn S., Marsden C.D., Calne D.B., Goldstein M. Recent Developments in Parkinsons Disease. II:1987;153-163 Macmillan Health Care Information, Florham Park, NJ.
8. Gardner W.N., Langdon N., Parkes J.D. Breathing in Parkinson's disease. Adv. Neurol. 45:1986;271-274.
9. Hovestadt A., Bogaard J.M., Meerwaldt J.D., van der Meché F.G.A., Stigt J. Pulmonary function in Parkinson's disease. J. Neurol. 52:1989;329-333.
10. Ilson J., Braun N., Fahn S. Respiratory fluctuations in Parkinson's disease. Neurology. 33(Suppl. 2):1983;113.
11. Muza S.R., Silverman M.T., Gilmore G.C., Hellerstein H.K., Kelsen S.G. Comparison of scales used to quantitate the sense of effort to breathe in patients with chronic obtructive pulmonary disease. Am. Rev. Respir. Dis. 141:1990;909-913.
12. Neu H.C., Connolly J.J., Fred J.R., Schwertley W., Ladwig H.A., Brody A.W. Obstructive respiratory dysfunction in parkinsonian patients. Am. Rev. Respir. Dis. 95:1967;33-47.
13. Nugent C.A., Harris H.W., Cohn J., Smith C.C., Tyler F.H. Dyspnea as a symptom in Parkinson's syndrome. Am. Rev. Tuber. 78:1958;682-691.
14. Obenour W.H., Stevens P.M., Cohen A.A., Mc Cutchen J.J. The causes of abnormal pulmonary function in Parkinson's disease. Am. Rev. Respir. Dis. 105:1972;382-387.
15. Pedersen M.E.F., Dorrington K.L., Robbins P.A. Effects of haloperidol on ventilation during isocapnic hypoxia in humans. J. Appl. Physiol. 83:1997;1110-1115.
16. Petit J.M., Delhez L. Activité électrique du diaphragme dans la maladie de Parkinson. Arch. Intern. Physiol. 69:1961;413-417.
17. Rimmer K.P., Ford G.T., Whitelaw W.A. Interaction between postural and respiratory control of human intercostal muscles. J. Appl. Physiol. 79:1995;1556-1561.
18. Sabate M., Rodriguez M., Mendez E., Enriquez E.R., Gonzalez I. Obstructive and restrictive pulmonary dysfunction increases disability in Parkinson's disease. Arch. Phys. Med. Rehabil. 77:1996;29-34.
19. Tzelepis G.E., Mc cool F.D., Friedman J.H., Hoppin F.G. Respiratory muscle dysfunction in Parkinson's disease. Am. Rev. Respir. Dis. 138:1988;266-271.
20. Vincken W.G., Gauthier S.G., Dollfuss R.E., Hanson R.E., Darauay C.M., Cosio M.G. Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N. Engl. J. Med. 311:1984;438-442.
21. Vincken W.G., Darauay C.M., Cosio M.G. Reversibility of upper airway obstruction after levodopa therapy in Parkinson's disease. Chest. 96:1989;210-212.
22. Welsh M.J., Heistad D., Abboud F.M. Depression of ventilation by dopamine in man. Evidence for an effect on the chemoreceptor reflex. J. Clinical. Invest. 61:1978;708-713.
23. Wermuth L., Stenager E.N., Stenager E., Boldsen J. Mortality in patients with Parkinson's disease. Acta Neurol. Scand. 92:1995;55-58.